Organogenesis Holdings Inc.Organogenesis Holdings Inc.Organogenesis Holdings Inc.

Organogenesis Holdings Inc.

No trades
See on Supercharts
Market capitalization
‪368.18 M‬USD
‪4.95 M‬USD
‪433.14 M‬USD
‪77.29 M‬
Beta (1Y)
1.37

About Organogenesis Holdings Inc.

CEO
Gary S. Gillheeney
Headquarters
Canton
Employees (FY)
862
Founded
1985
ISIN
US68621F1021
FIGI
BBG00FGGD295
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ORGO is 2.83 USD — it has increased by 1.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Organogenesis Holdings Inc. stocks are traded under the ticker ORGO.
Organogenesis Holdings Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ORGO stock is 3.07% volatile and has beta coefficient of 1.37. Check out the list of the most volatile stocks — is Organogenesis Holdings Inc. there?
One year price forecast for Organogenesis Holdings Inc. has a max estimate of 6.00 USD and a min estimate of 3.50 USD.
ORGO earnings for the last quarter are 0.04 USD whereas the estimation was 0.01 USD which accounts for 223.02% surprise. Estimated earnings for the next quarter are 0.01 USD. See more details about Organogenesis Holdings Inc. earnings.
Organogenesis Holdings Inc. revenue for the last quarter amounts to ‪108.53 M‬ USD despite the estimated figure of ‪111.43 M‬ USD. In the next quarter revenue is expected to reach ‪109.06 M‬ USD.
Yes, you can track Organogenesis Holdings Inc. financials in yearly and quarterly reports right on TradingView.
ORGO stock has fallen by 4.07% compared to the previous week, the month change is a 1.43% rise, over the last year Organogenesis Holdings Inc. has showed a 42.21% increase.
ORGO net income for the last quarter is ‪−568.00 K‬ USD, while the quarter before that showed ‪3.17 M‬ USD of net income which accounts for −117.93% change. Track more Organogenesis Holdings Inc. financial stats to get the full picture.
Today Organogenesis Holdings Inc. has the market capitalization of ‪368.18 M‬, it has increased by 13.79% over the last week.
No, ORGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ORGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Organogenesis Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.
ORGO reached its all-time high on Jan 9, 2019 with the price of 310.90 USD, and its all-time low was 1.80 USD and was reached on Apr 26, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 862.00 employees. See our rating of the largest employees — is Organogenesis Holdings Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Organogenesis Holdings Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Organogenesis Holdings Inc. stock shows the sell signal. See more of Organogenesis Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Organogenesis Holdings Inc. future price: according to them, ORGO price has a max estimate of 6.00 USD and a min estimate of 3.50 USD. Read a more detailed Organogenesis Holdings Inc. forecast: see what analysts think of Organogenesis Holdings Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Organogenesis Holdings Inc. EBITDA is ‪39.67 M‬ USD, and current EBITDA margin is 9.18%. See more stats in Organogenesis Holdings Inc. financial statements.